Immune Therapeutics, Inc.
$0.09▼ 7.00%($-0.01)
TickerSpark Score
41/100
▌ Weak
100
Valuation
40
Profitability
15
Growth
20
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMUN research report →
52-Week Range2% of range
Low
$0.07
Current
$0.09
High
$1.30
Company Overviewwww.immunetherapeutics.com
About the company
Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc.
- CEO
- Noreen M. Griffin
- IPO
- 2010
- HQ
- Winter Park, FL, US
Price Chart
-93.70% · this period
Valuation
- Market Cap
- $7.78M
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.52
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 67.11%
- ROIC
- 43.69%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-5,788,000 · -261.41%
- EPS
- $-0.16 · -102.16%
- Op Income
- $-1,163,000
- FCF YoY
- -366.87%
Performance & Tape
- 52W High
- $1.30
- 52W Low
- $0.07
- 50D MA
- $0.20
- 200D MA
- $0.48
- Beta
- 0.26
- Avg Volume
- 13.34K
Get TickerSpark's AI analysis on IMUN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 10, 23 | Farmer Glen A | buy | 409,000 |
| Jul 25, 22 | H. Louis Salomonsky Jr. Revocable Trust | other | 0 |
| Jul 25, 22 | Salomonsky Henry Louis | other | 0 |
| Jul 25, 22 | Salomonsky Henry Louis | other | 0 |
| Aug 2, 22 | Farmer Glen A | other | 0 |
| Aug 2, 22 | Farmer Glen A | other | 0 |
| Jun 30, 17 | Wilson Kelly O'Brien | other | 500 |
| Jul 25, 22 | Wilson Kelly O'Brien | other | 0 |
| Jul 25, 22 | Wilson Kelly O'Brien | other | 0 |
| Jul 25, 22 | Wilson Kelly O'Brien | other | 0 |
Coverage · IMUN
Our IMUN coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on IMUN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMUN report →Internal Compare
Similar companies
Peers in the same neighborhood.
TBPMF▼26.53%
Tetra Bio-Pharma Inc.
$0.00
FWPAY▼25.09%
Forward Pharma A/S
$300.00
POLXF▲0.30%
Polydex Pharmaceuticals Limited
$1.99
BNOEF▼14.89%
Bionomics Limited
$0.01
MXDHF▼9.09%
MDxHealth S.A.
$0.25
TRYPF▲32.24%
Tryp Therapeutics Inc.
$0.06
HBCNF▲2269.67%
HealthBeacon plc
$0.50
TPPRF▲0.00%
Top Strike Resources Corp.
$0.04